Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

1 Reason to Buy AT&T Stock, and 1 Reason to Avoid


The stock market has rendered its verdict on AT (NYSE: T) stock this year. While the S 500 is up around 10% year-to-date, shares of the telecom giant have tumbled roughly 20%.

There are some good reasons for the pessimism. The wireless industry has slowed this year, partly a hangover following a period of strong pandemic-era growth, and partly the result of an uncertain economic environment. AT still added just over 300,000 net postpaid phone subscribers during the second quarter, but that's less than half what it was adding each quarter throughout much of 2021 and 2022.

With AT stock trailing the broader market by such a wide margin while the wireless industry is becoming more competitive, it's understandable that many investors have written off the telecom giant entirely. But there's one good reason to seriously consider the stock.

Continue reading


Source Fool.com

Allergy Therapeutics PLC Aktie

0,051 €
3,06 %
Heute geht es für Allergy Therapeutics PLC stark aufwärts mit einem Zuwachs von 3,06 %.

Like: 0
T
Teilen

Kommentare